Home / Clinical Guideline Hubs / Chapter 8.9
Section 8 — Infectious Disease & Sepsis Pending expert review v1.0 · July 2026

Chapter 8.9 — Neonatal Immune Development, Host-Defense Vulnerability, and Primary Immunodeficiency

Board-review synthesis · pending expert review

Educational guideline — verify locally. Complements sepsis/infection guidelines (Section 8). Vaccine schedules/screening cut-offs vary by region — verify against current references and local protocols. Cross-references: sepsis (8.x), congenital infection/TORCH (8.x), 22q11.2 deletion (cardiac/endocrine).

1. Clinical Overview

Clinical Overview

The newborn's immunity is a work in progress, propped up by maternal support. Both innate (barriers, phagocytes, NK cells, complement, cytokines) and adaptive (B-cell antibody, T-cell responses) arms are present but immature, and the fetal system is biased toward tolerance — so the newborn fails fast and quietly against serious pathogens. Understanding the specific immaturities explains both susceptibility and the strategies used to protect the infant: borrowed transplacental IgG and breast-milk IgA, screening (SCID, congenital hypothyroidism, etc.), and timely immunisation. A small group of infants have a congenital defect (primary immunodeficiency); recognising the pattern — infections too severe, too frequent, too unusual, or too persistent — is the practical skill.

2. Key Clinical Points

Key Clinical Points
  • Two arms: innate (fast, non-specific — barriers, phagocytes, NK cells, complement, cytokines) and adaptive (specific, remembering — B cells make antibody, T cells run responses). Both are immature at birth.
  • IgG is the only immunoglobulin that crosses the placenta (passive immunity, mostly 3rd trimester); IgM does not cross, so elevated neonatal IgM = infant-made = intrauterine infection; IgA is dominant in breast milk (mucosal protection).
  • Neonatal host-defense deficits: thin/breached skin (worse in preterm and with indwelling lines), limited neutrophil number/function (count can FALL in overwhelming sepsis), and relatively deficient complement (reduced opsonisation).
  • The preterm is doubly disadvantaged — more fragile skin, more invasive procedures, more immature function, and less third-trimester maternal IgG. Infection presents non-specifically and progresses fast → low threshold for evaluation and empirical antibiotics.
  • Early-onset infection (first days) is acquired around birth from the maternal genital tract (obstetric risk factors); late-onset is from the postnatal/hospital environment (device-associated).
  • SCID (absent T-cell ± B/NK function) is a neonatal emergency now caught by newborn screening (absent T-cell production marker). On suspicion: avoid live vaccines, use irradiated/screened blood, involve immunology urgently; early immune reconstitution is curative, delay is fatal.
  • Suspect primary immunodeficiency when infections are too severe, too frequent, too unusual, or too persistent (± chronic thrush, chronic diarrhoea, failure to thrive, family history).
  • Pattern clues: antibody (B-cell) deficiencies present later as maternal IgG wanes; a neutrophil adhesion/movement defect classically shows delayed umbilical cord separation + recurrent infection + very high WBC; 22q11.2 deletion causes variable thymic hypoplasia/T-cell impairment (assess alongside cardiac lesion and hypocalcaemia).
  • Passive-then-active protection: transplacental IgG and breast-milk IgA cover early life but the borrowed IgG wanes, leaving a window of vulnerability; immunise the infant on schedule by CHRONOLOGICAL age (even in preterms), give hepatitis B at birth in many settings, and use maternal immunisation in pregnancy to reinforce borrowed antibody. Avoid live vaccines with suspected significant immunodeficiency.

3. References to Verify

Back to Clinical Guideline Hubs